Screener
LB Pharmaceuticals Inc LBRX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by LB Pharmaceuticals Inc in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219607
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Current liabilities | ||
| Accounts payable | $7,119 | $2,127 |
| Accrued expenses | 3,057 | 4,585 |
| Operating lease liabilities, current | 730 | 730 |
| Total current liabilities | 10,906 | 7,442 |
| Derivative liability - warrants | 1,143 | 1,343 |
| Operating lease liabilities, noncurrent | 2,740 | 2,839 |
| Total liabilities | 14,789 | 11,624 |
Item 1. Financial Statements
FAQ
- What is LB Pharmaceuticals Inc's operating lease liabilities (current)?
- LB Pharmaceuticals Inc (LBRX) reported operating lease liabilities (current) of $730K in Q1 2026.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about LB Pharmaceuticals Inc's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude